Skip to content

Different Strategies for Preventing Severe Acute Malnutrition in Niger

Different Strategies for Preventing Severe Acute Malnutrition in Niger: a Pragmatic Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01828814
Enrollment
7836
Registered
2013-04-11
Start date
2011-07-31
Completion date
2012-10-31
Last updated
2017-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malnutrition

Keywords

pediatrics, Ready-to-use Supplementary Food, corn soy blend, cash transfer, prevention of malnutrition, Niger

Brief summary

Options for large-scale preventive distributions include fortified blended flours, ready-to-use foods and direct cash transfer either alone or in combination with family protective rations. Finding the most appropriate strategy is essential to prevent child malnutrition in countries like Niger with annual hunger gaps. Here, the investigators compare different preventive strategies on the incidence of acute malnutrition among children 6 to 23 months.

Interventions

None listed

Sponsors

United Nations World Food Programme (WFP)
CollaboratorOTHER
Epicentre
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 24 Months
Healthy volunteers
Yes

Inclusion criteria

* resident in selected villages * height between 60 and 80 cm.

Exclusion criteria

* refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Incidence of severe acute malnutrition15 monthsSevere acute malnutrition was defined as : Weight for Height Z-score (WHO Standards 2006)\< -3 and/or mid-upper arm circumference (MUAC) \< 115mm and/or bipedal oedema. MUAC was measured at the midpoint of a child's left arm with a plastic measuring tape with a precision of 1 mm. These indicators were evaluated monthly during the entire follow-up (15 months).

Secondary

MeasureTime frameDescription
Mortalityduration of follow-up (15 months)Mortality events include all reports for which the cause for absence from surveillance visits was reported to be death by a family member.

Countries

Niger

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026